6:11 PM
 | 
Sep 25, 2013
 |  BC Extra  |  Politics & Policy

FDA blasts ANDA Citizen's Petitions

FDA said Citizen's Petitions requesting specific action on ANDA and 505(b)(2) NDAs for a specific drug often "do not raise valid scientific issues and are intended primarily to delay the approval of competing drug products." Responding...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >